-23% EBITDA 143 211 -32% 286 -50% อัตราก้าไร EBITDA (%) 5.1% 4.6% 0.5% 7.8% -2.7% Stock Gain/(Loss) & NRV -74 -233 -68% -24 208% Adjusted EBITDA(1) 217 444 -51% 310 -30% Adjusted EBITDA Margin (%) 7.7
) 302.9% Profit (loss) of the year 450.1 17.5% (466.9) (12.2%) (916.9) (203.7%) Adjusted items Net unrealized loss on exchange rate - - 39.2 1.0% 39.2 - Non-recurring items2 (138.7) (5.4%) 329.3 8.6% 467.9
-45% EBITDA Margin (%) 4.6% 7.3% -2.7% 7.4% -2.8% Stock Gain/(Loss) & NRV -233 -33 606% -62 276% Adjusted EBITDA(1) 444 345 29% 449 -1% Adjusted EBITDA Margin (%) 9.6% 8.1% 1.5% 8.6% 1.0% ก ำไรสทุธิ 64
aspects of their business is vital to the investor. [ 4 ] Engagement—direct communication between investors and companies—on environmental, social and governance matters is on the rise in the United States
ะหข์องฝ่ายจัดการ | 2 หมายเหตุ : (1) Adjusted EBITDA คือ EBITDA ที(ไม่รวมผลกระทบจาก Stock Gain/(Loss) และ ค่าเผื(อมูลค่าของสนิคา้คงเหลือ (NRV) บทสรปุผูบ้รหิาร ในปี 2560 ภาพรวมของผลผลิตปาล์มนํ5ามันทั 5งใน
9,073 -2% EBITDA 137 228 -40% 211 -35% 348 540 -36% EBITDA Margin (%) 3.2% 4.7% -1.5% 4.6% -1.4% 3.9% 6.0% -2.1% Stock Gain/(Loss) & NRV -149 -425 -65% -233 -36% -382 -458 -17% Adjusted EBITDA(1) 286 653
135.2 18.9 (201.9) (11.5) (249.3%) Adjusted EBITDA1 266.0 37.2 461.6 26.3 73.6% Adjusted profit (loss) for the year 135.5 18.9 (163.0) (9.3) (220.3%) Adjusted profit (loss) for the year after non
, according to higher cost. Moreover, to keep market share, company needed to launch price promotion in vital channel. Financial results of 9-month ended period ● Considering year to date result, total sales
accordance with the guidelines for renewal of approval for investor contacts as prescribed by the Office. The prescription is to ensure that investor contacts who play vital roles in the capital market will
knowledge in accordance with the guidelines for renewal of approval for investor contacts as prescribed by the Office. The prescription is to ensure that investor contacts who play vital roles in the capital